Actively Recruiting
Using 100Hz Respiratory-Gated Vagus Nerve Stimulation to Improve Apathy in Parkinsons Disease A Randomized Double-Blind Study
Led by Anhui Medical University · Updated on 2025-11-19
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether 100Hz respiratory-gated auricular vagus nerve stimulation RAVANS can improve apathy and other non-motor symptoms in people with Parkinsons disease PD. This randomized, double-blind, sham-controlled trial aims to assess the safety and effects of 100Hz RAVANS compared to a low-dose sham stimulation. The study focuses on measuring changes in apathy and other symptoms using various assessments and biological samples. Participants are randomly assigned to receive either active 100Hz RAVANS or sham stimulation once daily. Each session lasts 30 minutes and is delivered for two weeks, with stimulation timed to the participants breathing cycle. The real stimulation targets the auricular branch of the vagus nerve on the left ear, while the sham involves low-dose stimulation at the same site and parameters. Before and after the two-week treatment period, participants undergo neuropsychological tests, brain imaging, and biological sample collection. Researchers will evaluate apathy using the Apathy Motivation Index and track other non-motor symptoms, sleep quality, fatigue, anxiety, depression, heart rate variability, and motor function at multiple time points up to 10 weeks. Safety and side effects are also monitored throughout the study.
CONDITIONS
Brief Title
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
Research Team
R
Rong Ye, Ph.D.
P
Panpan Hu, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here